In a small clinical trial, customized mRNA vaccines against high-risk skin cancers appeared to reduce the risk of cancer recurrence and death by nearly 50 percent over five years when compared with ...

COVID-19 proved that mRNA vaccines can work. Now, researchers are applying the technology to other diseases. More than half of Americans are fully vaccinated against COVID-19. Many of them received an ...

Messenger RNA, or mRNA, vaccines entered the public consciousness when they were introduced during the COVID-19 pandemic, and both Pfizer-BioNTech and Moderna used the technology in developing their ...

At the World Economic Forum, CEO Stéphane Bancel expressed concern about the US vaccine market but remained committed to ...

Flu vaccines that take a page from the COVID-19 vaccine platform are making progress in clinical trials. In a phase 3 trial, Pfizer’s mRNA flu vaccine outperformed a traditional vaccine, researchers ...

RESUME FLIGHTS TONIGHT. FIVE ON YOUR HEALTH TONIGHT THE FUTURE FOR MRNA VACCINES IS IN JEOPARDY. HHS SECRETARY ROBERT F KENNEDY JR HAS CUT HUNDREDS OF MILLIONS OF DOLLARS IN FUNDING FOR THEM. WELL, A ...

Alex Hogan is STAT’s senior multimedia producer and host of STATus Report, STAT’s weekly video series. You can follow him on Bluesky. Anil Oza is a general assignment reporter at STAT focused on the ...